Development of therapeutic tumor vaccines or a variety of gene therapeutics based on non-viral or viral gene delivery system.
Development of dendritic cell (DC)-based immune cell therapeutics.
Target disease: malignant tumors (cervix, prostate, lung, brain, liver, etc), incurable infectious diseases (Hepatitis B and C virus, herpes simplex virus type 2, human papilloma viruses, avian flu, etc.).
Development of non-viral gene delivery system in a mode of high safety and stability in human blood.
Development of tissue-specific (i.e., tumor-specific) and strong gene expression vectors
Development of large-scale production technology of the therapeutic plasmid DNA with a high purity through a cost-effective E. coli fermentation system.
11F Mario Digital Tower 222-12 Guro-dong Guro-gu Seoul Korea post:152-050 / TEL : 02-2088-0055~8, FAX : 02-3409-1330
copyright (c) 2006 goodgene.co.kr all right reserved